AD is characterized by two proteinopathies: amyloidopathy, a product of the abnormal cleavage of the amyloid precursor protein (APP), which leads to the accumulation of Aβ peptide in senile or amyloid plaques; and tauopathy, which is due to Tau hyperphosphorylation and aggregation. This evidence concerns the gene APP and proteostasis deficiencies.